Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: A population-based study
The Lancet Regional Health - Americas（2022）
摘要
The National Institute of Diabetes and Digestive and Kidney Disease (R01DK115534, K24HL155861, and K01DK121825).
更多查看译文
关键词
Obesity,Obesogenic medications,Socioeconomic status,Disparities,Pharmacoequity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要